| Literature DB >> 23052389 |
Valeria Cento1, Carmen Mirabelli1, Salvatore Dimonte1, Romina Salpini1, Yue Han2, Pascale Trimoulet3, Ada Bertoli4, Valeria Micheli5, Guido Gubertini5, Giuseppina Cappiello6, Alberto Spanò6, Roberta Longo6, Martina Bernassola6, Francesco Mazzotta7, Giuseppe Maria De Sanctis8, Xin Xin Zhang2, Jens Verheyen9, Antonella D'Arminio Monforte10, Francesca Ceccherini-Silberstein1, Carlo Federico Perno1, Valentina Svicher1.
Abstract
How the overlap between the hepatitis B virus (HBV) reverse transcriptase (RT) and HBV S antigen (HBsAg) genes modulates the extent of HBV genetic variability is still an open question, and was investigated here. The rate of nucleotide conservation (≤1% variability) followed an atypical pattern in the RT gene, due to an overlap between RT and HBsAg (69.9% nucleotide conservation in the overlapping region vs 41.2% in the non-overlapping region; P<0.001), with a consequently lower rate of synonymous substitution within the overlapping region [median(interquartile range)dS=3.1(1.5-7.4) vs 20.1(10.6-30.0); P=3.249×10(-22)]. The most conserved RT regions were located within the YMDD motif and the N-terminal parts of the palm and finger domains, critical for RT functionality. These regions also corresponded to highly conserved HBsAg domains that are critical for HBsAg secretion. Conversely, the genomic region encoding the HBsAg antigenic loop (where immune-escape mutations are localized) showed a sharp decrease in the extent of conservation (40.6%), which was less pronounced in the setting of human immunodeficiency virus (HIV)-driven immune suppression (48.8% in HIV-HBV co-infection vs 21.5% in mono-infected patients; P=0.020). In conclusion, the overlapping reading frame and the immune system appear to have shaped the patterns of RT and HBsAg genetic variability. Highly conserved regions in RT and HBsAg may deserve further attention as novel therapeutic targets.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23052389 DOI: 10.1099/vir.0.046524-0
Source DB: PubMed Journal: J Gen Virol ISSN: 0022-1317 Impact factor: 3.891